Shares of Incannex Healthcare Inc. hit their highest levels in nearly two months on Wednesday after the company released ...

While sleep apnea is relatively common and known for affecting breathing during rest hours, its impact on long-term health is ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

A recent study revealed that Obstructive sleep apnea , commonly linked with cardiovascular and metabolic disorders, plays a ...

OSA-related hypoxemia linked to increased frontoparietal cerebrovascular pathology, which is associated with reduced medial temporal lobe integrity.

Eight Sleep Eight Sleep's latest innovation is here: The Pod 5. Like the company's earlier versions of the Pod, it's designed ...

Call Scheduled for Thursday, May 15, 2025 at 5:00 pm ETLITTLETON, Colo., May 14, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device ...

Preliminary screening for OSA in children who are awake, performed via an EEG, may help identify whether oxygen desaturation occurs at night.

IHL-42X is designed to treat OSA by targeting its underlying pathophysiology. An oral fixed-dose combination of dronabinol and acetazolamide, IHL-42X is currently advancing through the RePOSA Phase ...

Dr. David Koh, a pioneer in sleep disorders and a proud member of the Asian American and Pacific Islander community, ...

Reduced oxygen during REM sleep was associated with cerebrovascular damage in areas of the brain associated with memory and ...